All Stories

  1. Limonene and its metabolite perillyl alcohol inhibit Chlamydia trachomatis growth by altering host isoprenoid metabolism
  2. Febuxostat analogs as anti-quorum sensing and antibacterial agents
  3. Antibacterial and anti-biofilm properties of Cymbopogon martini (Roxb.) essential oil and geraniol against Staphylococcus aureus strains
  4. Drop-on-demand antimicrobial printed coatings loaded with a dehydroabietic acid derivative to prevent orthopedic implant infections
  5. Potent antimicrobial and anti-biofilm effects of Uvaria chamae on Staphylococcus aureus strains via potential cell wall interference and lack of resistance induction
  6. Chlamydia pneumoniae relies on host glutathione for its growth and induces integrated stress response-mediated changes in macrophage glutathione metabolism
  7. Anesthetic-like effects of ketamine in C. elegans
  8. Medicines and the environment : challenges and solutions for sustainable pharmacy
  9. Pharmacy Undergraduates’ Epistemic Cognition and Medication Beliefs as Predictors of Conceptual Learning and Academic Progress
  10. Anesthetic-like effects of ketamine inC. elegans
  11. A new in vivo model to study the interactions between intracellular bacteria with their host
  12. Synthesis andantibacterial profiling of new derivatives of an immunomodulatory drug
  13. Lääkkeet ja ympäristö : kestävän lääkehuollon haasteita ja ratkaisuja
  14. Local knowledge, practices, challenges of ethnopharmacologically used medicinal plants in Benin and implications for brain illnesses
  15. Impact of azithromycin, doxycycline and redox-active small molecules on amoxicillin-induced Chlamydia pneumoniae persistence
  16. Clinical reasoning in pharmacy: What do eye movements and verbal protocols tell us about the processing of a case task?
  17. Unleashing the Potential of Medicinal Plants in Benin: Assessing the Status of Research and the Need for Enhanced Practices
  18. Repurposing the Sphingosine-1-Phosphate Receptor Modulator Etrasimod as an Antibacterial Agent Against Gram-Positive Bacteria
  19. Alterations in Bacterial Metabolism Contribute to the Lifespan Extension Exerted by Guarana in Caenorhabditis elegans
  20. A proteomics study on how Chlamydia pneumoniae affects macrophages
  21. The influence of dibenzocyclooctadiene lignans on macrophage glutathione and lipid metabolism associated with Chlamydia pneumoniae-induced foam cell formation
  22. University students' study progress
  23. Correction: Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
  24. a model to study C. pneumoniae infection
  25. Growth Mode and Physiological State of Cells Prior to Biofilm Formation Affect Immune Evasion and Persistence of Staphylococcus aureus
  26. Assaying Chlamydia pneumoniae Persistence in Monocyte-Derived Macrophages Identifies Dibenzocyclooctadiene Lignans as Phenotypic Switchers
  27. Assaying Chlamydia pneumoniae persistence in monocyte-derived macrophages identifies schisandrin lignans as phenotypic switchers
  28. Impact of dibenzocyclooctadiene lignans from Schisandra chinensis on the redox status and activation of human innate immune system cells
  29. Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy
  30. Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
  31. Lead Discovery Strategies for Identification of Chlamydia pneumoniae Inhibitors
  32. Amphipathic β2,2-Amino Acid Derivatives Suppress Infectivity and Disrupt the Intracellular Replication Cycle of Chlamydia pneumoniae
  33. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses
  34. Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis
  35. Inhibitory Activity of the Isoflavone Biochanin A on Intracellular Bacteria of Genus Chlamydia and Initial Development of a Buccal Formulation
  36. How to Translate a Bioassay Into a Screening Assay for Natural Products: General Considerations and Implementation of Antimicrobial Screens
  37. Recent advances in technologies for developing drugs againstChlamydia pneumoniae
  38. Tailored beads made of dissolved cellulose—Investigation of their drug release properties
  39. Commercial peppermint (Mentha×piperita L.) teas: Antichlamydial effect and polyphenolic composition
  40. Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques
  41. Aggregating Behavior of Phenolic Compounds — A Source of False Bioassay Results?
  42. Ent-kauren-19-oic acid derivatives from the stem bark of Croton pseudopulchellus Pax
  43. Conformation study of 2-arylbenzimidazoles as inhibitors of Chlamydia pneumoniae growth
  44. Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays
  45. Effects of coadministration of natural polyphenols with doxycycline or calcium modulators on acute Chlamydia pneumoniae infection in vitro
  46. Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae
  47. The Binding of Synthetic Retinoids to Lipocalin β-Lactoglobulins
  48. Betulin-Derived Compounds as Inhibitors of Alphavirus Replication
  49. A luciferase-based screening method for inhibitors of alphavirus replication applied to nucleoside analogues
  50. Comparison of transgenic Gerbera hybrida lines and traditional varieties shows no differences in cytotoxicity or metabolic fingerprints
  51. Predictive value of cellular methods in toxicological evaluation of lead candidates: an insight to hepatotoxicity
  52. Assessing the data quality in predictive toxicology using a panel of cell lines and cytotoxicity assays